BrainLAB Announces Availability of iPlan® RT Treatment Planning Platform

BrainLAB AG has announced the availability of the complete iPlan^® RT treatment planning platform.

Unveiled at the 2006 Annual Meeting of The American Association of Physicists in Medicine (AAPM), iPlan RT is designed to offer clinicians and physicists the ability to combine various radiotherapy and radiosurgery treatment modalities, improved workflow, and increased visibility throughout the planning process.

Furthermore, iPlan RT is fully integrated in the BrainLAB Intelligent Treatment Framework that brings together radiotherapy with surgery and chemotherapy in a comprehensive oncology approach.

Each patient and their disease is unique. Sophisticated diagnostic imaging information is a critical part of determining a patient's disease.

Clinicians are using iPlan RT to leverage all available patient images to define the individual's disease.

Once defined, targeting complex tumors with a highly precise radiosurgery treatment dose requires a wide range of specialized tools in order to develop the most comprehensive treatment plan for each patient.

The iPlan RT Dose software is designed to allow physicians to choose between all available radiation treatment modalities such as conformal beam, dynamic conformal arc, and IMRT, or a combination of these different modalities, which offers clinicians the flexibility to compose the individual treatment approach.

Additionally, clinicians can efficiently customize the treatment plan according to each patient's specific requirements by using various automatic and template-based planning features.

Intuitive 2D, 3D, and animated views also provide full visibility and allow for better-informed placement decisions to ensure safe treatment planning.

iPlan RT Dose is the final component of the iPlan multi-disciplinary software platform, providing capabilities in target definition and stereotactic radiosurgery treatment planning.

Dr. Timothy Solberg, Professor and Chief of Medical Physics at the University of Nebraska Medical Center, has been using iPlan RT for approximately four months.

"New planning systems do not come out that often - normally it's just a few software upgrades," said Dr. Solberg.

"The BrainLAB iPlan RT platform, however, represents a new paradigm in seamlessly integrating all different treatment modalities like conformal, dynamic arc, and IMRT in one plan for a best possible treatment."

"iPlan RT offers powerful new tools built into a very intuitive user interface, and the quality of plans and ease of use is unmatched."

"We can use this for all modalities, not just radiosurgery, thus it provides an extension into our extra-cranial and IMRT treatments."

"We have also started to export the results of unique iPlan functions such as the atlas automatic organ segmentation into our existing RT planning system utilizing the DICOM RT standard."

"With the completion of our iPlan RT platform, clinicians now have access to a powerful portfolio of tools in one hospital-wide solution," said Ralf Schira, Global Marketing Manager, BrainLAB AG.

"Difficult to treat indications can now be planned faster, more flexible and with better results then ever before."

"As part of our commitment to develop the latest in oncology treatment technology, BrainLAB continues to collaborate closely with top medical institutions around the world."

"Thereby we can provide a comprehensive treatment approach leveraging biological data, the latest imaging modalities and advanced simulation algorithms such as Monte Carlo."

For more information about iPlan RT Dose and the iPlan treatment platform, visit BrainLAB at Booth # 415 at the 2006 AAPM Annual Meeting.